Sign in
4

Changes in Ownership

NewAmsterdam Pharma Co N.V. Filed Acc 0001193125-26-019686

Chief Financial Officer sold 100,000 shares at an average $32.61 ($3,260,618)

  • Chief Financial Officer acquired 100,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Somaiya Mayur Ian · Chief Financial Officer

Table I: Non-derivative

7 lines
Date Transaction Shares Price Value Owned after D/I
2026-01-20 Exercise or conversion : show line 1 in the form 10b5-1 +60,216 $9.26 $557,600 118,598 D
2026-01-20 Sale : show line 2 in the form 10b5-1 −900 $30.64 $27,576 117,698 D
2026-01-20 Sale : show line 3 in the form 10b5-1 −39,712 $31.78 $1,262,047 77,986 D
2026-01-20 Sale : show line 4 in the form 10b5-1 −19,604 $32.38 $634,778 58,382 D
2026-01-21 Exercise or conversion : show line 5 in the form 10b5-1 +39,784 $9.26 $368,400 98,166 D
2026-01-21 Sale : show line 6 in the form 10b5-1 −15,422 $33.25 $512,782 82,744 D
2026-01-21 Sale : show line 7 in the form 10b5-1 −24,362 $33.80 $823,436 58,382 D
Open-market sales · 100,000 sh · avg $32.61 · $3,260,618

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-01-20 Exercise or conversion : show line 8 in the form 10b5-1 Option (Right to Buy) −60,216 702,598 D
2026-01-21 Exercise or conversion : show line 9 in the form 10b5-1 Option (Right to Buy) −39,784 662,814 D
Loading xslF345X05/ownership.xml…